Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

High Mir-17-92 Expression Is Associated with in Vitro chemoresistance in Burkitt Lymphoma

Thomas Ippolito, MSc, Rodney R. Miles, MD PhD, Vladimir Rodic, Cory Mavis, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Matthew J. Barth, MD

Blood (2018) 132 (Supplement 1): 1586.

https://doi.org/10.1182/blood-2018-99-118932

Published: 2018

Journal Articles

Microrna (miR)-17-92 Contributes to Therapy Resistance in Burkitt Lymphoma Cells

Rodney R. Miles, MD PhD, Vladimir Rodic, Matthew J. Barth, MD, Mitchell S. Cairo, MD, Michelle L. Hermiston, MD PhD

Blood (2016) 128 (22): 2944.

https://doi.org/10.1182/blood.V128.22.2944.2944

Published: 2016

Journal Articles

Transcription Activator-Like Effector Nucleases (TALENs)-Mediated Deletion Of MIR17HG In Burkitt Lymphoma Cells Decreases mTOR Pathway Activity and Increases Chemosensitivity

Faye Pais, Ph.D., Sanghoon Lee, Ph.D, MSc., Vladimir Rodic, Matthew J. Barth, MD, Mitchell S. Cairo, MD, Michelle L. Hermiston, MD, PhD, Rodney R. Miles, MD, PhD

Blood (2013) 122 (21): 243.

https://doi.org/10.1182/blood.V122.21.243.243

Published: 2013

Journal Articles

Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia

D. Spencer Mangum, MD, Soheil Shams, PhD, Jonathan M. Downie, BS, Uta von Schwedler, PhD, Vladimir Rodic, PhD, Michael Engel, MD, PhD, Phillip Barnette, MD, J. Kimble Frazer, MD, PhD, Nikolaus Trede, MD, PhD, Dequing Pei, PhD, Cheng Cheng, PhD, Ching-Hon Pui, MD, Stephen P Hunger, MD, Jun J. Yang, PhD, Rodney R. Miles, MD, PhD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Joshua D. Schiffman, MD

Blood (2011) 118 (21): 741.

https://doi.org/10.1182/blood.V118.21.741.741

Published: 2011

Journal Articles

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

Jonathan Downie, BS, Phillip Barnette, MD, Vladimir Rodic, BS, J. Kimble Frazer, MD, PhD, Nikolaus Trede, MD, PhD, Meenakshi Devidas, PhD, Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Stephen Hunger, MD, Rodney R. Miles, MD, PhD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 275.

https://doi.org/10.1182/blood.V116.21.275.275

Published: 2010

Journal Articles

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

Rodney R. Miles, MD, PhD, Jonathan Downie, BS, Mona S. Jahromi, BS, Deepa Joshi, BS, Vladimir Rodic, BS, Markus Muschen, MD, Jun J. Yang, PhD, William E. Evans, PharmD, Nathan Meeker, MD, Nikolaus Trede, MD, PhD, J. Kimble Frazer, MD, PhD, Phillip Barnette, MD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 273.

https://doi.org/10.1182/blood.V116.21.273.273

Published: 2010

Journal Articles

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

Joshua D. Schiffman, MD, Patrick D. Lorimer, BS, Vladimir Rodic, BS, Mona S. Jahromi, BS, Jonathan M. Downie, BS, Michael G. Bayerl, MD, Sherrie L. Perkins, MD, PhD, Phillip Barnette, MD, Rodney R. Miles, MD, PhD

Blood (2010) 116 (21): 3123.

https://doi.org/10.1182/blood.V116.21.3123.3123

Published: 2010

Journal Articles

Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Childhood Leukemia.

Schiffman D. Schiffman, MD, Jonathan Downie, BS, Bradley Demarest, MS, Roberto Montenegro, PhD, Vladimir Rodic, BS, Phillip Barnette, MD, Rodney R. Miles, MD, PhD

Blood (2009) 114 (22): 1589.

https://doi.org/10.1182/blood.V114.22.1589.1589

Published: 2009

NARROW

High Mir-17-92 Expression Is Associated with in Vitro chemoresistance in Burkitt Lymphoma

Microrna (miR)-17-92 Contributes to Therapy Resistance in Burkitt Lymphoma Cells

Transcription Activator-Like Effector Nucleases (TALENs)-Mediated Deletion Of MIR17HG In Burkitt Lymphoma Cells Decreases mTOR Pathway Activity and Increases Chemosensitivity

Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Childhood Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only